Liabilities / Assets
80th percentile
Higher debt load relative to assets than 80% of similar nonprofits.
Peptide Therapeutics Foundation
990EZ • Fiscal year 2015 • EIN 26-3728931
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.15x
Liabilities / Revenue
91st percentile
Higher debt load relative to revenue than 91% of similar nonprofits.
Net Margin
79th percentile
Higher net margin than 79% of similar nonprofits.
Top Officer Pay
75th percentile
Higher top officer pay than 75% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
64th percentile
Faster asset growth than 64% of similar nonprofits.
Revenue Growth
54th percentile
Faster revenue growth than 54% of similar nonprofits.
Balance Sheet
Assets
Up$389,214
Up $40,443 (+12%) from 2014
Net Assets
Up$331,155
Up $32,303 (+11%) from 2014
Liabilities
Up$58,059
Up $8,140 (+16%) from 2014
Revenue And Expenses
Revenue
Up$142,758
Up $5,083 (+3.7%) from 2014
Expenses
Down$110,455
Down $2,563 (-2.3%) from 2014
Net Income
Up$32,303
Up $7,646 (+31%) from 2014
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2015 to Dec 31, 2015
- Signed
- Jun 22, 2016
- Return Version
- 2015v2.1
- Gross Receipts
- $142,758
Mission and Program Overview
Mission
The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 29 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. | - | $110,455 |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| ABHIJIT BHAT PHD | Vice Preside | - | $0 | - | - |
| MARIA BEDNAREK PHD | Fellow & Hea | - | $0 | - | - |
| KONRAD BLEICHER PHD | Peptide Area | - | $0 | - | - |
| RICHARD DIMARCHI PHD | Professor & | - | $0 | - | - |
| SOUMITRA GHOSH PHD | President | - | $0 | - | - |
| KELD FOSGERAU PHD | SVP & Head O | - | $0 | - | - |
| RODNEY LAX PHD | Sr Director Of B | - | $0 | - | - |
| PANKAJ R PATEL | Chairman & D | - | $0 | - | - |
| CLAUDIO SCHTEINGART PHD | VP Science & | - | $0 | - | - |
| ADRIENNE DAY PHD | Bd.Sec. & Tr | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Peptide Therapeutics Foundation
- EIN
- 26-3728931
- Phone
- 8586571511
- Address
- 4245 SORRENTO VALLEY BLVD, SAN DIEGO, CA 92121
Signing Officer
- Name
- Adrienne Day Phd
- Title
- Bd.sec. & Treasurer
- Phone
- 8586571511
- Signed
- 2016-06-22
Preparer
- Firm
- GOODSELL & COMPANY INC CPA'S
- Address
- 2665 4TH AVE, SAN DIEGO, CA 92103-6514
- Preparer
- Steven J Holc CPA
- Phone
- 6192384343
Supplemental Narrative
Additional Explanations
Form 990-ez, Part I, Line 8
“Other revenue 128 total 128”
Form 990-ez, Part I, Line 16
“Expenses symposium expenses 99,960 foundation maintenance 5,640 board expenses 2,589 miscellaneous 126 total 108,315”
Form 990-ez, Part II, Line 26
“Accrued symposium expense 49,919 58,059”
Form 990-ez, Part III
“The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.”
Form 990-ez, Part III, Line 28
“Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 29 postdoctoral fellows and graduate students with free registration to the symposium.”
Raw XML Appendix180 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | THE ORGANIZATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 8586571511 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 4245 SORRENTO VALLEY BLVD |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | SAN DIEGO |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92121 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 348771 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 389214 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/ContributionsGiftsGrantsEtcAmt | 0 | 104970 |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | 32303 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 2140 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 348771 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 389214 |
| IRS990EZ/GrossReceiptsAmt | 0 | 142758 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 298852 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 331155 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 298852 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 331155 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 6 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 7 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 8 | 0.25 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 9 | 2.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 6 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 7 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 8 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 9 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | ABHIJIT BHAT PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | MARIA BEDNAREK PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | KONRAD BLEICHER PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | RICHARD DIMARCHI PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | SOUMITRA GHOSH PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | KELD FOSGERAU PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 6 | RODNEY LAX PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 7 | PANKAJ R PATEL |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 8 | CLAUDIO SCHTEINGART PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 9 | ADRIENNE DAY PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | VICE PRESIDE |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | FELLOW & HEA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | PEPTIDE AREA |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | PROFESSOR & |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | PRESIDENT |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | SVP & HEAD O |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 6 | SR DIR. OF B |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 7 | CHAIRMAN & D |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 8 | VP SCIENCE & |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 9 | BD.SEC. & TR |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 108315 |
| IRS990EZ/OtherRevenueTotalAmt | 0 | 128 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 37660 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 29 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 110455 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 49919 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 58059 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 110455 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 110455 |
| IRS990EZ/TotalRevenueAmt | 0 | 142758 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.PEPTIDETHERAPEUTICS.ORG |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | OTHER INCOME 2,013 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | PART III, LINE 12 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt | 0 | 104970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 104940 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 77440 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 114970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 139970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 542290 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 37788 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 32735 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 42876 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 52819 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 57090 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 223308 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.00000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.00000 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 2013 |
| IRS990ScheduleA/OtherIncome509Grp/TotalAmt | 0 | 2013 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.99740 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.99740 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 765598 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 142758 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 137675 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 120316 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 167789 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 197060 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 765598 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 142758 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 137675 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 122329 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 167789 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 197060 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 767611 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | OTHER REVENUE 128 TOTAL 128 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | EXPENSES SYMPOSIUM EXPENSES 99,960 FOUNDATION MAINTENANCE 5,640 BOARD EXPENSES 2,589 MISCELLANEOUS 126 TOTAL 108,315 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | ACCRUED SYMPOSIUM EXPENSE 49,919 58,059 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 29 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 8 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990-EZ, PART III, LINE 28 |
| ReturnHeader/BuildTS | 0 | 2016-09-27 15:27:22Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ADRIENNE DAY PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | BD.SEC. & TREASURER |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8586571511 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2016-06-22 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | PEPTIDE THERAPEUTICS FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | PEPT |
| ReturnHeader/Filer/EIN | 0 | 263728931 |
| ReturnHeader/Filer/PhoneNum | 0 | 8586571511 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 4245 SORRENTO VALLEY BLVD |
| ReturnHeader/Filer/USAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92121 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 331005644 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | GOODSELL & COMPANY INC CPA'S |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 2665 4TH AVE |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 921036514 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6192384343 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2016-06-22 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | STEVEN J HOLC CPA |
| ReturnHeader/ReturnTs | 0 | 2016-06-22T14:32:15-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2015-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2015-12-31 |
| ReturnHeader/TaxYr | 0 | 2015 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2015 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $389,214
- Liabilities
- $58,059
- Net assets
- $331,155
- Revenue
- $142,758
- Expenses
- $110,455
- Net income
- $32,303